Literature DB >> 25491687

Soluble Cell Adhesion Molecules - Does Estimating sVCAM-1 and sICAM-1 Concentration Provide Additional Information About Cardiovascular Risk in Patients with Coronary Artery Disease?

Anna Hulok1, Krzysztof Sciborski1, Jakub Marczak2, Tomasz Bańkowski1, Rafał Poręba3, Marta Negrusz-Kawecka1.   

Abstract

OBJECTIVES: Cell adhesion molecules (CAM) are thought to have a great impact on endothelium functioning. Interaction between CAM and a receptor may lead to macrophage activation and the release of multiple enzymes such as elastases and colagenases. These enzymes can, in turn, play a role in atherosclerotic plaque destabilization and initiation of acute coronary syndrome (ACS). The main aim of this study was to assess the role of sVCAM-1 and sICAM-1 in the risk stratification of ACS.
MATERIAL AND METHODS: 63 patients - mean age 62.7 ± 9.5 years (26 women, 37 men) - were included in the study. Patients were divided into two groups: I - patients with acute coronary syndrome (ACS) diagnosed by coronary angiography (n = 45: 15 women; 30 men); and II - patients without apparent CAD in coronary angiography (n = 18: 11 women, 7 men). In both groups, samples required for sVCAM-1 and sICAM-1 level measurements were collected before the angiography.
RESULTS: Mean age, prevalence of arterial hypertension, diabetes mellitus and chronic kidney disease did not differ between the groups. Levels of sVCAM-1 and sICAM-1 were significantly higher in group I (group I vs. group II: 850.3 ± 337.9 vs. 675.9 ± 178.8; p = 0.02 and 737.2 ± 353.5 vs. 428.5 ± 157.3; p = 0.001 respectively). ROC analysis revealed that there is significantly higher risk of ACS above the level of 700.15 ng/mL for sVCAM-1 and 407.8 ng/mL for sICAM-1. The level of sVCAM-1 was also found to be an independent risk factor of NSTEMI, OR 1.003 (95% CI: 1.0007-1.004); p = 0.007, but not of STEMI (p > 0.05).
CONCLUSIONS: Levels of sVCAM-1 and sICAM-1 were found to be negative predictors of acute coronary syndrome. Further studies should assess the relationship between sVCAM-1 and sICAM-1 levels and the survival of patients suffering from CAD.

Entities:  

Year:  2014        PMID: 25491687     DOI: 10.17219/acem/37232

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  5 in total

Review 1.  An integrated approach to coronary heart disease diagnosis and clinical management.

Authors:  Teresa Infante; Ernesto Forte; Concetta Schiano; Carlo Cavaliere; Carlo Tedeschi; Andrea Soricelli; Marco Salvatore; Claudio Napoli
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

Review 2.  ICAM-1 molecular mechanism and genome wide SNP's association studies.

Authors:  C Anbarasan; M Bavanilatha; K Latchumanadhas; S Ajit Mullasari
Journal:  Indian Heart J       Date:  2015-05-16

3.  Increased Soluble VCAM-1 and Normal P-Selectin in Cystic Fibrosis: a Cross-Sectional Study.

Authors:  Jan K Nowak; Irena Wojsyk-Banaszak; Edyta Mądry; Andrzej Wykrętowicz; Patrycja Krzyżanowska; Sławomira Drzymała-Czyż; Agata Nowicka; Andrzej Pogorzelski; Ewa Sapiejka; Wojciech Skorupa; Mariusz Szczepanik; Aleksandra Lisowska; Jaroslaw Walkowiak
Journal:  Lung       Date:  2017-06-23       Impact factor: 2.584

Review 4.  ICAM-1 gene rs5498 polymorphism decreases the risk of coronary artery disease.

Authors:  Ailing Liu; Ailing Wan; Aifang Feng; Ruping Rui; Bingzhi Zhou
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

5.  Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome.

Authors:  Kim M Keppler-Noreuil; Jay Lozier; Neal Oden; Anjali Taneja; Jasmine Burton-Akright; Julie C Sapp; Leslie G Biesecker
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-09-06       Impact factor: 3.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.